Peer Learning Collaboratives
Member Benefit
ACH Learning Collaboratives
Advocates for Community Health (ACH) Learning Collaboratives (LC) are an educational approach using fresh ideas, inventive thinking, and actions to enhance learning by working together with other health center leaders and experts in the field. Through these collaboratives, ACH unites various disciplines to address the pressing issues facing health centers today, and as community health challenges shift and develop, so do the topics. LCs are an opportunity for ACH’s health center leaders to directly tackle health care challenges and equip themselves with tangible knowledge to enact real change.
What to Expect
Practice-Based Learning & Action
While webinars are educational presentations where attendees typically submit questions or comments after the presentation, participants in a LC engage as a group to discuss the concepts presented and engage in peer-to-peer learning by sharing ideas, asking questions, debating, and listening to other perspectives. Participants may also develop or pilot tools and resources that are shared in a learning session to help reach their goals.
Upcoming 340B Learning Collaborative
ACH’s 340B new Learning Collaborative (LC) will conduct a deep exploration of the 340B Drug Pricing Program as it plays a significant role in improving access to affordable medications for underserved populations. 340B LC members, alongside experts in the field, will share the latest information on and best practices about 340B in order to better understand the intricacies of the program and navigate its complexities. Participants will gain a better grasp of 340B to identify opportunities for optimizing patient care, reducing health disparities, and ultimately enhancing the sustainability of healthcare systems.
Format & Program
Over the course of five months, senior staff of ACH member community health centers will meet in-person in Washington, DC and via virtual learning sessions.
- Face-to-Face and Virtual Workshops: The LCs will meet in person and through virtual workshops (via Zoom) between November 2024 and March 2025. The first learning session – a 1.5-day event – and final meeting will be in-person events that will take place in Washington, DC. Each subsequent virtual workshop will be one hour in length and provide a deep-dive presentation on a topic specifically relevant to the peer group’s interest. Faculty will include ACH and Equiscript leaders, subject matter experts, and other FQHCs peers who will share best practices.
- Wrap-up Session: The final learning session will take place in March 2025 as a pre-meeting event during ACH’s Annual Member Meeting.
Learning Objectives
340B LC participants will:
- Gain a comprehensive understanding of the 340B Drug Pricing Program.
- Learn strategies to optimize the financial benefits of the 340B program to help their organizations better support patients.
- Share and implement best practices for managing the 340B program effectively.
- Learn how to advocate for necessary policy changes and reforms related to the 340B program by understanding current legislative proposals – such as 340C – and engaging with key policymakers.
- Build a network of peers and stakeholders within the 340B community to foster collaboration, share experiences, and enhance collective knowledge regarding program implementation and challenges.
Participant Commitment & Expectations
Participants are expected to attend and actively engage in all virtual and in-person sessions, and submit reporting requirements as needed. They must:
- Attend and commit to all learning sessions;
- Participate in individualized study (individual and small group exercises);
- and, respond to workshop and LC evaluations.
Note: Participants are required to pay for their own travel, including but not limited to, airfare, hotel, and meals during the in-person sessions in Washington, DC.
Thank you to our generous 340B Learning Collaborative Sponsor
